[1]
„Simvastatin is effective in killing the radioresistant breast carcinoma cells“, Radiol Oncol, let. 55, št. 3, str. 305–316, jul. 2021, Pridobljeno: avg. 03, 2026. Dostopno na: https://www.ojstest.computing.si/index.php/ro/article/view/3679